S. Valitutti, S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia, Serial triggering of many T-cell receptors by a few peptide???MHC complexes, Nature, vol.375, issue.6527, pp.148-151, 1995.
DOI : 10.1038/375148a0

J. D. Altman, P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. Mcheyzer-williams et al., Phenotypic Analysis of Antigen-Specific T Lymphocytes, Science, vol.274, issue.5284, pp.94-96, 1996.
DOI : 10.1126/science.274.5284.94

H. Kozono, J. White, J. Clements, P. Marrack, and J. Kappler, Production of soluble MHC class II proteins with covalently bound single peptides, Nature, vol.369, issue.6476, pp.151-154, 1994.
DOI : 10.1038/369151a0

F. Crawford, H. Kozono, J. White, P. Marrack, and J. Kappler, Detection of Antigen-Specific T Cells with Multivalent Soluble Class II MHC Covalent Peptide Complexes, Immunity, vol.8, issue.6, pp.675-682, 1998.
DOI : 10.1016/S1074-7613(00)80572-5

B. L. Kotzin, M. T. Falta, F. Crawford, E. F. Rosloniec, J. Bill et al., Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis, Proceedings of the National Academy of Sciences, vol.97, issue.1, pp.291-296, 2000.
DOI : 10.1073/pnas.97.1.291

J. R. Cochran, T. O. Cameron, and L. J. Stern, The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers, Immunity, vol.12, issue.3, pp.241-250, 2000.
DOI : 10.1016/S1074-7613(00)80177-6

T. O. Cameron, J. R. Cochran, B. Yassine-diab, R. P. Sekaly, and L. J. Stern, Cutting Edge: Detection of Antigen-Specific CD4+ T Cells by HLA-DR1 Oligomers Is Dependent on the T Cell Activation State, The Journal of Immunology, vol.166, issue.2, pp.741-745, 2001.
DOI : 10.4049/jimmunol.166.2.741

H. Quarsten, S. N. Mcadam, T. Jensen, H. Arentz-hansen, O. Molberg et al., Staining of Celiac Disease-Relevant T Cells by Peptide-DQ2 Multimers, The Journal of Immunology, vol.167, issue.9, pp.4861-4868, 2001.
DOI : 10.4049/jimmunol.167.9.4861

E. J. Novak, A. W. Liu, G. T. Nepom, and W. W. Kwok, MHC class II tetramers identify peptide-specific human CD4+ T cells proliferating in response to influenza A antigen, Journal of Clinical Investigation, vol.104, issue.12, pp.63-67, 1999.
DOI : 10.1172/JCI8476

T. Sturniolo, E. Bono, J. Ding, L. Raddrizzani, O. Tuereci et al., Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices, Nat. Biotechnol, vol.17, pp.555-561, 1999.

E. J. Novak, A. W. Liu, J. A. Gebe, B. A. Falk, G. T. Nepom et al., Tetramer-Guided Epitope Mapping: Rapid Identification and Characterization of Immunodominant CD4+ T Cell Epitopes from Complex Antigens, The Journal of Immunology, vol.166, issue.11, pp.6665-6670, 2001.
DOI : 10.4049/jimmunol.166.11.6665

W. W. Kwok, J. A. Gebe, A. Liu, S. Agar, N. Ptacek et al., Rapid epitope identification from complex class-II-restricted T-cell antigens, Trends in Immunology, vol.22, issue.11, pp.583-588, 2001.
DOI : 10.1016/S1471-4906(01)02038-5

V. Monsurro, D. Nagorsen, E. Wang, M. Provenzano, M. E. Dudley et al., Functional Heterogeneity of Vaccine-Induced CD8+ T Cells, The Journal of Immunology, vol.168, issue.11, pp.5933-5942, 2002.
DOI : 10.4049/jimmunol.168.11.5933

E. J. Novak, S. A. Masewicz, A. W. Liu, A. Lernmark, W. W. Kwok et al., Activated human epitope-specific T cells identified by class II tetramers reside within a CD4high, proliferating subset, International Immunology, vol.13, issue.6, pp.799-806, 2001.
DOI : 10.1093/intimm/13.6.799

W. W. Kwok, A. W. Liu, E. J. Novak, J. A. Gebe, R. A. Ettinger et al., HLA-DQ Tetramers Identify Epitope-Specific T Cells in Peripheral Blood of Herpes Simplex Virus Type 2-Infected Individuals: Direct Detection of Immunodominant Antigen-Responsive Cells, The Journal of Immunology, vol.164, issue.8, pp.4244-4249, 2000.
DOI : 10.4049/jimmunol.164.8.4244

S. Reichstetter, R. A. Ettinger, A. W. Liu, J. A. Gebe, G. T. Nepom et al., Distinct T Cell Interactions with HLA Class II Tetramers Characterize a Spectrum of TCR Affinities in the Human Antigen-Specific T Cell Response, The Journal of Immunology, vol.165, issue.12, pp.6994-6998, 2000.
DOI : 10.4049/jimmunol.165.12.6994

H. Reijonen, E. J. Novak, S. Kochik, A. Heninger, A. W. Liu et al., Detection of GAD65-Specific T-Cells by Major Histocompatibility Complex Class II Tetramers in Type 1 Diabetic Patients and At-Risk Subjects, Diabetes, vol.51, issue.5, pp.1375-1382, 2002.
DOI : 10.2337/diabetes.51.5.1375

A. L. Meyer, C. Trollmo, F. Crawford, P. Marrack, A. C. Steere et al., Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers, Proceedings of the National Academy of Sciences, vol.97, issue.21, pp.11433-11438, 2000.
DOI : 10.1073/pnas.190335897

J. J. Boniface, J. D. Rabinowitz, C. Wulfing, J. Hampl, Z. Reich et al., Initiation of Signal Transduction through the T Cell Receptor Requires the Multivalent Engagement of Peptide/MHC Ligands, Immunity, vol.9, issue.4, pp.459-466, 1998.
DOI : 10.1016/S1074-7613(00)80629-9

D. J. Irvine, M. A. Purbhoo, M. Krogsgaard, D. , and M. M. , Direct observation of ligand recognition by T cells, Nature, vol.90, issue.6909, pp.845-849, 2002.
DOI : 10.1126/science.282.5397.2266

Z. Reich, J. J. Boniface, D. S. Lyons, N. Borochov, E. J. Wachtel et al., Ligandspecific oligomerization of T-cell receptor molecules, Nature, vol.387, pp.617-620, 1997.

S. Valitutti and A. Lanzavecchia, Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition, Immunology Today, vol.18, issue.6, pp.299-304, 1997.
DOI : 10.1016/S0167-5699(97)80027-8

A. R. Hamad, S. M. O-'herrin, M. S. Lebowitz, A. Srikrishnan, J. Bieler et al., Potent T Cell Activation with Dimeric Peptide???Major Histocompatibility Complex Class II Ligand: The Role of CD4 Coreceptor, The Journal of Experimental Medicine, vol.136, issue.9, pp.1633-1640, 1998.
DOI : 10.1002/eji.1830240427

S. Casares, C. S. Zong, D. L. Radu, A. Miller, C. A. Bona et al., Antigen-Specific Signaling by a Soluble, Dimeric Peptide/Major Histocompatibility Complex Class II/Fc Chimera Leading to T Helper Cell Type 2 Differentiation, The Journal of Experimental Medicine, vol.15, issue.4, pp.543-553, 1999.
DOI : 10.1146/annurev.immunol.15.1.563

H. Appel, L. Gauthier, J. Pyrdol, and K. W. Wucherpfennig, Kinetics of T-cell receptor binding by bivalent HLA-DR.Peptide complexes that activate antigen-specific human T-cells

L. C. Wu, D. S. Tuot, D. S. Lyons, K. C. Garcia, D. et al., Two-step binding mechanism for T-cell receptor recognition of peptide???MHC, Nature, vol.14, issue.6897, pp.552-556, 2002.
DOI : 10.1107/S0021889891004399

I. Stefanova, J. R. Dorfman, G. , and R. N. , Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes, Nature, vol.151, issue.6914, pp.429-434, 2002.
DOI : 10.1084/jem.186.5.757

C. Wulfing, C. Sumen, M. D. Sjaastad, L. C. Wu, M. L. Dustin et al., Costimulation and endogenous MHC ligands contribute to T cell recognition, Nature Immunology, vol.3, issue.1, pp.42-47, 2002.
DOI : 10.1038/ni741

C. A. London, M. P. Lodge, and A. K. Abbas, Functional Responses and Costimulator Dependence of Memory CD4+ T Cells, The Journal of Immunology, vol.164, issue.1, pp.265-272, 2000.
DOI : 10.4049/jimmunol.164.1.265

J. S. Goldstein, T. Chen, M. Brunswick, H. Mostowsky, and S. Kozlowski, Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions, J. Immunol, 1998.

J. A. Bluestone, New perspectives of C1328-137-mediated T cell costimulation, Immunity, vol.2, issue.6, pp.555-559, 1995.
DOI : 10.1016/1074-7613(95)90000-4

H. Appel, N. P. Seth, L. Gauthier, and K. W. Wucherpfennig, Anergy Induction by Dimeric TCR Ligands, The Journal of Immunology, vol.166, issue.8, pp.5279-5285, 2001.
DOI : 10.4049/jimmunol.166.8.5279

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414419

J. B. Latouche and M. Sadelain, Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells, Nat. Biotechnol, vol.18, pp.405-409, 2000.

M. V. Maus, A. K. Thomas, D. G. Leonard, D. Allman, K. Addya et al., Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB, Nature Biotechnology, vol.20, issue.2, pp.28-32, 2002.
DOI : 10.1038/nbt0202-143

M. V. Maus, J. L. Riley, W. W. Kwok, G. T. Nepom, J. et al., HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells, Clinical Immunology, vol.106, issue.1, pp.16-22, 2003.
DOI : 10.1016/S1521-6616(02)00017-7

V. I. Mallet-designe, T. Stratmann, D. Homann, F. Carbone, M. B. Oldstone et al., Detection of Low-Avidity CD4+ T Cells Using Recombinant Artificial APC: Following the Antiovalbumin Immune Response, The Journal of Immunology, vol.170, issue.1, pp.123-131, 2003.
DOI : 10.4049/jimmunol.170.1.123

C. N. Baxevanis, I. F. Voutsas, O. E. Tsitsilonis, A. D. Gritzapis, R. Sotiriadou et al., Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor, The Journal of Immunology, vol.164, issue.7, pp.3902-3912, 2000.
DOI : 10.4049/jimmunol.164.7.3902

A. L. Marzo, B. F. Kinnear, R. A. Lake, J. J. Frelinger, E. J. Collins et al., Tumor-Specific CD4+ T Cells Have a Major "Post-Licensing" Role in CTL Mediated Anti-Tumor Immunity, The Journal of Immunology, vol.165, issue.11, pp.6047-6055, 2000.
DOI : 10.4049/jimmunol.165.11.6047

K. Hung, R. Hayashi, A. Lafond-walker, C. Lowenstein, D. Pardoll et al., T Cells in the Antitumor Immune Response, The Journal of Experimental Medicine, vol.156, issue.12, pp.2357-2368, 1998.
DOI : 10.1084/jem.179.2.447

D. M. Pardoll and S. L. Topalian, The role of CD4+ T cell responses in antitumor immunity, Current Opinion in Immunology, vol.10, issue.5, pp.588-594, 1998.
DOI : 10.1016/S0952-7915(98)80228-8

R. F. Wang, The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity, Trends in Immunology, vol.22, issue.5, pp.269-276, 2001.
DOI : 10.1016/S1471-4906(01)01896-8

S. Casares, A. Hurtado, R. C. Mcevoy, A. Sarukhan, H. Von-boehmer et al., Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide???MHC class II chimera, Nature Immunology, vol.3, issue.4, pp.383-391, 2002.
DOI : 10.1038/ni770

L. Zuo, C. M. Cullen, M. L. Delay, S. Thornton, L. K. Myers et al., A Single-Chain Class II MHC-IgG3 Fusion Protein Inhibits Autoimmune Arthritis by Induction of Antigen-Specific Hyporesponsiveness, The Journal of Immunology, vol.168, issue.5, pp.2554-2559, 2002.
DOI : 10.4049/jimmunol.168.5.2554

O. 'herrin, S. M. Slansky, J. E. Tang, Q. Markiewicz, M. A. Gajewski et al., Antigen-Specific Blockade of T Cells In Vivo Using Dimeric MHC Peptide, The Journal of Immunology, vol.167, issue.5, pp.2555-2560, 2001.
DOI : 10.4049/jimmunol.167.5.2555

J. M. Critchfield, M. K. Racke, J. C. Zuniga-pflucker, B. Cannella, C. S. Raine et al., T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis, Science, vol.263, issue.5150, pp.1139-1143, 1994.
DOI : 10.1126/science.7509084

R. C. Budd, Activation-induced cell death, Current Opinion in Immunology, vol.13, issue.3, pp.356-362, 2001.
DOI : 10.1016/S0952-7915(00)00227-2

J. Dhein, H. Walczak, C. Baumler, K. M. Debatin, and P. H. Krammer, Autocrine T-cell suicide mediated by APO-1/(Fas/CD95), Nature, vol.373, issue.6513, pp.438-441, 1995.
DOI : 10.1038/373438a0

T. Brunner, R. J. Mogil, D. Laface, N. J. Yoo, A. Mahboubi et al., Fas- ligand interaction mediates activation-induced apoptosis in T-cell hybridomas, Cell-autonomous Fas Nature, vol.373, issue.CD95, pp.441-444, 1995.

J. D. Laman, E. Claassen, N. , and R. J. , Functions of CD40 and Its Ligand, gp39 (CD40L), Critical Reviews??? in Immunology, vol.16, issue.1, pp.59-108, 1996.
DOI : 10.1615/CritRevImmunol.v16.i1.40

N. H. Ruddle, Tumor necrosis factor (TNF-??) and lymphotoxin (TNF-??), Current Opinion in Immunology, vol.4, issue.3, pp.327-332, 1992.
DOI : 10.1016/0952-7915(92)90084-R

B. K. English, W. M. Weaver, W. , and C. B. , Differential regulation of lymphotoxin and tumor necrosis factor genes in human T lymphocytes, J. Biol. Chem, vol.266, pp.7108-7113, 1991.

G. Screaton and X. N. Xu, T cell life and death signalling via TNF-receptor family members, Current Opinion in Immunology, vol.12, issue.3, pp.316-322, 2000.
DOI : 10.1016/S0952-7915(00)00093-5

F. K. Chan, R. M. Siegel, and M. J. Lenardo, Signaling by the TNF Receptor Superfamily and T Cell Homeostasis, Immunity, vol.13, issue.4, pp.419-422, 2000.
DOI : 10.1016/S1074-7613(00)00041-8

D. S. Vinay and B. S. Kwon, Role of 4-1BB in immune responses, Seminars in Immunology, vol.10, issue.6, pp.481-489, 1998.
DOI : 10.1006/smim.1998.0157

M. Ahmad, S. M. Srinivasula, R. Hegde, R. Mukattash, T. Fernandes-alnemri et al., Identification and characterization of murine caspase-14, a new member of the caspase family, Cancer Res, vol.58, pp.5201-5205, 1998.

L. H. Boise, M. Gonzalez-garcia, C. E. Postema, L. Ding, T. Lindsten et al., bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell, vol.74, issue.4, pp.597-608, 1993.
DOI : 10.1016/0092-8674(93)90508-N

J. M. Adams, C. , and S. , Life-or-death decisions by the Bcl-2 protein family, Trends in Biochemical Sciences, vol.26, issue.1, pp.61-66, 2001.
DOI : 10.1016/S0968-0004(00)01740-0

D. Homann, L. Teyton, and M. B. Oldstone, Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory, Nature Medicine, vol.7, issue.8, pp.913-919, 2001.
DOI : 10.1038/90950

J. D. Trudeau, C. Kelly-smith, C. B. Verchere, J. F. Elliott, J. P. Dutz et al., Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood, Journal of Clinical Investigation, vol.111, issue.2, pp.217-223, 2003.
DOI : 10.1172/JCI200316409

K. C. Herold, J. A. Bluestone, A. G. Montag, A. Parihar, A. Wiegner et al., Prevention of Autoimmune Diabetes With Nonactivating Anti-CD3 Monoclonal Antibody, Diabetes, vol.41, issue.3, pp.385-391, 1992.
DOI : 10.2337/diab.41.3.385

K. C. Herold, W. Hagopian, J. A. Auger, E. Poumian-ruiz, L. Taylor et al., Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus, New England Journal of Medicine, vol.346, issue.22, pp.1692-1698, 2002.
DOI : 10.1056/NEJMoa012864

E. L. Masteller and J. A. Bluestone, Immunotherapy of insulin-dependent diabetes mellitus, Current Opinion in Immunology, vol.14, issue.5, pp.652-659, 2002.
DOI : 10.1016/S0952-7915(02)00375-8

L. Chatenoud, CD3-specific antibody-induced active tolerance: from bench to bedside, Nature Reviews Immunology, vol.3, issue.2, pp.123-132, 2003.
DOI : 10.1038/nri1000

P. J. Higgins and H. L. Weiner, Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments, Journal of Neuroimmunology, vol.16, issue.1, pp.440-445, 1988.
DOI : 10.1016/0165-5728(87)90246-3

D. E. Smilek, D. C. Wraith, S. Hodgkinson, S. Dwivedy, L. Steinman et al., A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis., Proceedings of the National Academy of Sciences, vol.88, issue.21, pp.9633-9637, 1991.
DOI : 10.1073/pnas.88.21.9633

D. Daniel and D. R. Wegmann, Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)., Proceedings of the National Academy of Sciences, vol.93, issue.2, pp.956-960, 1996.
DOI : 10.1073/pnas.93.2.956

J. Tian, M. Clare-salzler, A. Herschenfeld, B. Middleton, D. Newman et al., Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes???prone mice, Nature Medicine, vol.150, issue.12, pp.1348-1353, 1996.
DOI : 10.1016/0167-4781(93)90056-J

D. Elias and I. R. Cohen, Peptide therapy for diabetes in NOD mice, The Lancet, vol.343, issue.8899, pp.704-706, 1994.
DOI : 10.1016/S0140-6736(94)91582-2

B. Bielekova, B. Goodwin, N. Richert, I. Cortese, T. Kondo et al., Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand, Nat. Med, vol.6, pp.1167-1175, 2000.

L. Kappos, G. Comi, H. Panitch, J. Oger, J. Antel et al., Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group, Nat. Med, vol.6, pp.1176-1182, 2000.

L. Chaillous, H. Lefevre, C. Thivolet, C. Boitard, N. Lahlou et al., Oral insulin administration and residual (??-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial, The Lancet, vol.356, issue.9229, pp.545-549, 2000.
DOI : 10.1016/S0140-6736(00)02579-4

I. Raz, D. Elias, A. Avron, M. Tamir, M. Metzger et al., ??-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial, The Lancet, vol.358, issue.9295, pp.1749-1753, 2001.
DOI : 10.1016/S0140-6736(01)06801-5

G. Y. Ishioka, L. Adorini, J. C. Guery, F. C. Gaeta, R. Lafond et al., Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides, J. Immunol, vol.152, pp.4310-4319, 1994.

C. P. Genain and S. S. Zamvil, Specific immunotherapy: one size does not fit all, Nature Medicine, vol.6, issue.10, pp.1098-1100, 2000.
DOI : 10.1038/80424

S. Casares, C. A. Bona, and T. D. Brumeanu, Enzymatically mediated engineering of multivalent MHC class II-peptide chimeras, Protein Engineering Design and Selection, vol.14, issue.3, 2001.
DOI : 10.1093/protein/14.3.195

C. L. Vanderlugt and S. D. Miller, EPITOPE SPREADING IN IMMUNE-MEDIATED DISEASES: IMPLICATIONS FOR IMMUNOTHERAPY, Nature Reviews Immunology, vol.4, issue.2, pp.85-95, 2002.
DOI : 10.1128/JVI.75.7.3077-3088.2001

R. Mallone, E. Ortolan, S. Pinach, M. Volante, M. M. Zanone et al., Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies, Diabetologia, vol.45, pp.1667-1677, 2002.